CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein

被引:60
作者
Zhang, Y
Morrone, G
Zhang, JX
Chen, XA
Lu, XL
Ma, L
Moore, M
Zhou, PB
机构
[1] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Program Mol Biol, New York, NY 10021 USA
[3] Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Lab Dev Hematopoiesis, New York, NY 10021 USA
[5] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA
[6] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy
关键词
CUL-4A; hematopoiesis; homeodomain; HOXA9; proteolysis; RNAi; ubiquitin;
D O I
10.1093/emboj/cdg577
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HOXA9 homeodomain protein is a key regulator of hematopoiesis and embryonic development. HOXA9 is expressed in primitive hematopoietic cells, and its prompt downregulation is associated with myelocytic maturation. Although transcriptional inactivation of HOXA9 during hematopoietic differentiation has been established, little is known about the biochemical mechanisms underlying the subsequent removal of HOXA9 protein. Here we report that the CUL-4A ubiquitylation machinery controls the stability of HOXA9 by promoting its ubiquitylation and proteasome-dependent degradation. The homeodomain of HOXA9 is responsible for CUL-4A-mediated degradation. Interfering CUL-4A biosynthesis by ectopic expression or by RNA-mediated interference resulted in alterations of the steady-state levels of HOXA9, mirrored by impairment of the ability of 32D myeloid progenitor cells to undergo proper terminal differentiation into granulocytes. These results revealed a novel regulatory mechanism of hematopoiesis by ubiquitin-dependent proteolysis.
引用
收藏
页码:6057 / 6067
页数:11
相关论文
共 34 条
[1]   The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9 [J].
Borrow, J ;
Shearman, AM ;
Stanton, VP ;
Becher, R ;
Collins, T ;
Williams, AJ ;
Dube, I ;
Katz, F ;
Kwong, YL ;
Morris, C ;
Ohyashiki, K ;
Toyama, K ;
Rowley, J ;
Housman, DE .
NATURE GENETICS, 1996, 12 (02) :159-167
[2]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[3]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[4]  
Chen LC, 1998, CANCER RES, V58, P3677
[5]   UV-damaged DNA-binding proteins are targets of CUL-4A-mediated ubiquitination and degradation [J].
Chen, XA ;
Zhang, Y ;
Douglas, L ;
Zhou, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) :48175-48182
[6]   SCF and cullin/RING H2-based ubiquitin ligases [J].
Deshaies, RJ .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :435-467
[7]  
Freshney IR, 2000, CULTURE ANIMAL CELLS
[8]   Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes [J].
Fujino, T ;
Yamazaki, Y ;
Largaespada, DA ;
Jenkins, NA ;
Copeland, NG ;
Hirokawa, K ;
Nakamura, T .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (07) :856-863
[9]   The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1 [J].
Furukawa, M ;
Zhang, YP ;
McCarville, J ;
Ohta, T ;
Xiong, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (21) :8185-8197
[10]   HOMEODOMAIN PROTEINS [J].
GEHRING, WJ ;
AFFOLTER, M ;
BURGLIN, T .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :487-526